Alector Ties Up With Genentech on Brain-Penetrant GCase Therapy, Putting $1.27B in Potential Deal Value on the Table
Market Chameleon (Mon, 5-Oct 9:54 AM)
Alector licenses brain-penetrant AL050 to Genentech, led by $100 million upfront and up to $1.17 billion in milestones
Market Chameleon (Mon, 5-Oct 8:13 AM)
